Bioxodes
PrivateLast Round
Series B
Dec 10, 2025
Total Funding Raised
$25.25M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bioxodes is a clinical-stage biopharmaceutical company that develops therapies to treat thrombotic and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bioxodes Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bioxodes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Dec 10, 2025 | ||||
| Series A Extension | Feb 12, 2025 | ||||
| Grant | Nov 21, 2023 | ||||
| Series A | Nov 21, 2023 | ||||
| Seed | Nov 26, 2013 | ||||
Grant | Nov 1, 2013 |
Bioxodes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Federal Holding and Investment Company | Series A Extension |
| Newton Biocapital | Series B |
| Life Sciences Research Partners | Series B, Seed, Series A Extension, Series A |
| European Regional Development Fund | Grant, Seed |
| Financière Spin-off Luxembourgeoise | Series B, Seed, Series A Extension, Series A |
| Walloon Region (Belgium) | Seed, Series A |
| Sambrinvest | Series B, Seed, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 18, 2026
Monthly visitors increased 64% MoM, reaching 2.1K.
- Apr 17, 2026
BIOX-101 for ICH is in dialogue with regulators for pivotal trial design.
Bioxodes Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bioxodes's valuation, stock price, and market status.